Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	573M 0 492M 461M 422M 795M 54.76B 797M 5.46B 2.13B 27.6B 2.15B 2.11B 91.34B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	573M 0 492M 461M 422M 795M 54.76B 797M 5.46B 2.13B 27.6B 2.15B 2.11B 91.34B	EV / Sales 2026 *	8.34x	EV / Sales 2027 *	6.82x
Free-Float	90.5%	Yield 2026 *	-	Yield 2027 *	-

13/08	BrainsWay Shares Rise After Higher Q2 Results	MT
13/08	BrainsWay Ltd., Q2 2026 Earnings Call, Aug 12, 2026
12/08	BrainsWay Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/08	BrainsWay Ltd. Raises Earnings Guidance for the Fiscal Year 2026	CI
21/07	Radial Health, S.C. announced that it has received $53 million in funding from a group of investors	CI
20/07	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
16/07	Sound Minds Behavioral announced that it expects to receive $0.5 million in funding from BrainsWay Ltd.	CI
16/07	BrainsWay Announces Strategic Investment in Sound Minds Behavioral	MT
29/06	Brainsway Ltd. Presents Positive Data From Largest Real-World Study Of Deep TMS In Patients With Comorbid PTSD And Major Depressive Disorder	CI
09/06	BrainsWay Presents First SWIFT Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	CI
18/05	Hopemark Health, Ltd announced that it expects to receive funding from BrainsWay Ltd.	CI
18/05	Brainsway announces minority-stake investment in Hopemark Health	RE
18/05	BrainsWay Takes Minority Stake in Hopemark Health	MT

20/07	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
13/11	BrainsWay Ltd. Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents Aged 15 to 21	CI
15/05/25	Oppenheimer Adjusts Brainsway Price Target to $15 From $13, Maintains Outperform Rating	MT
10/05/24	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
10/05/24	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

09:31pm	BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation	AQ
12/08	BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights	AQ
29/07	BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026	AQ
20/07	BrainsWay Announces Strategic Investment in Radial Health, Inc.	AQ
16/07	BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral	AQ

Manager	Title	Age	Since
Hadar Levy CEO	Chief Executive Officer	54	13/02/2023
Yiftach Roth CTO	Chief Tech/Sci/R&D Officer	56	01/05/2006
Ido Marom DFI	Director of Finance/CFO	50	23/05/2023

Brainsway Ltd Stock TEL AVIV STOCK EXCHANGE

Stocks

IL0011007189

Advanced Medical Equipment & Technology

Valuation : Brainsway Ltd

Latest news : Brainsway Ltd

Last Transcript : Brainsway Ltd

Analysts' recommendations : Brainsway Ltd

Press Releases : Brainsway Ltd

Quotes and Performance

Managers and Directors : Brainsway Ltd

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Director	Title	Age	Since
David Zacut CHM	Chairman	74	01/01/2003
Avner Hagai BRD	Director/Board Member	70	01/11/2006
Abraham Zangen BRD	Director/Board Member	56	17/06/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAINSWAY LTD	-0.67%	-6.36%	-	-	573M
THERMO FISHER SCIENTIFIC, INC.	-0.45%	+0.67%	+29.43%	+15.88%	234B
DANAHER CORPORATION	+0.33%	+0.15%	+5.48%	-17.31%	151B
INTUITIVE SURGICAL, INC.	-0.61%	-1.65%	-21.83%	+22.17%	131B
BOSTON SCIENTIFIC CORPORATION	-2.50%	-4.99%	-55.70%	-12.80%	69.81B
EDWARDS LIFESCIENCES CORPORATION	-0.72%	+0.63%	+11.74%	+18.90%	52.33B
SIEMENS HEALTHINEERS AG	0.00%	-1.38%	-16.80%	-14.19%	50.91B
AGILENT TECHNOLOGIES, INC.	+1.13%	+0.23%	+32.00%	+30.64%	43.8B
WATERS CORPORATION	+1.88%	+4.36%	+43.34%	+50.05%	40.69B
RESMED, INC.	+0.62%	+3.66%	-16.02%	+46.28%	34B
Average	-0.08%	+0.04%	+1.29%	+15.51%	89.79B
Weighted average by Cap.	-0.23%	-0.04%	+4.16%	+10.30%

	2026 *	2027 *
Net sales	68.73M 0 59M 55.23M 50.58M 95.28M 6.56B 95.55M 654M 256M 3.31B 258M 252M 10.95B	84.08M 0 72.17M 67.57M 61.87M 117M 8.03B 117M 800M 313M 4.05B 316M 309M 13.39B
Net income	10.9M 0 9.36M 8.76M 8.02M 15.11M 1.04B 15.15M 104M 40.55M 525M 40.92M 40.04M 1.74B	20.11M 0 17.26M 16.16M 14.8M 27.88M 1.92B 27.96M 191M 74.82M 968M 75.51M 73.88M 3.2B
Net Debt	-	-